Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial

被引:61
作者
Diletti, Roberto [1 ]
Farooq, Vasim [1 ]
Girasis, Chrysafios [1 ]
Bourantas, Christos [1 ]
Onuma, Yoshinobu [1 ]
Heo, Jung Ho [1 ]
Gogas, Bill D. [1 ]
van Geuns, Robert-Jan [1 ]
Regar, Evelyn [1 ]
de Bruyne, Bernard [2 ]
Dudek, Dariusz [3 ]
Thuesen, Leif [4 ]
Chevalier, Bernard [5 ]
McClean, Dougal [6 ]
Windecker, Stephan [7 ]
Whitbourn, Robert J. [8 ]
Smits, Pieter [9 ]
Koolen, Jacques [10 ]
Meredith, Ian [11 ]
Li, Xiaolin [12 ]
Miquel-Hebert, Karine [13 ]
Veldhof, Susan [13 ]
Garcia-Garcia, Hector M. [14 ]
Ormiston, John A. [15 ]
Serruys, Patrick W. [1 ]
机构
[1] Erasmus MC, Intervent Cardiol Dept, Thoraxctr, NL-3015 CE Rotterdam, Netherlands
[2] Cardiovasc Ctr Aalst, Dept Intervent Cardiol, Aalst, Belgium
[3] Jagiellonian Univ, Dept Cardiol, Krakow, Poland
[4] Aarhus Univ Hosp, Skejby Sygehus, Dept Cardiol, DK-8000 Aarhus, Denmark
[5] Inst Hosp Jacques Cartier, Dept Cardiol, Massy, France
[6] Christchurch Hosp, Dept Cardiol, Christchurch, New Zealand
[7] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland
[8] St Vincents Hosp, Dept Cardiol, Fitzroy, Vic 3065, Australia
[9] Maasstad Ziekenhuis Rotterdam, Dept Intervent Cardiol, Rotterdam, Netherlands
[10] Catharina Hosp, Dept Intervent Cardiol, Eindhoven, Netherlands
[11] Monash Med Ctr, Dept Intervent Cardiol, Melbourne, Vic, Australia
[12] Abbott Vasc, Santa Clara, CA USA
[13] Abbott Vasc, Diegem, Belgium
[14] Cardialysis BV, Rotterdam, Netherlands
[15] Auckland City Hosp, Dept Cardiol, Auckland, New Zealand
关键词
OPTICAL COHERENCE TOMOGRAPHY; CORONARY-ARTERY-DISEASE; BALLOON ANGIOPLASTY; STENT IMPLANTATION; FOLLOW-UP; RESTENOSIS; 2ND-GENERATION; ULTRASOUND; PLACEMENT; HISTOLOGY;
D O I
10.1136/heartjnl-2012-302598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The long-term results after second generation everolimus eluting bioresorbable vascular scaffold (Absorb BVS) placement in small vessels are unknown. Therefore, we investigated the impact of vessel size on long-term outcomes, after Absorb BVS implantation. Methods In ABSORB Cohort B Trial, out of the total study population (101 patients), 45 patients were assigned to undergo 6-month and 2-year angiographic follow-up (Cohort B1) and 56 patients to have angiographic follow-up at 1-year (Cohort B2). The pre-reference vessel diameter (RVD) was <2.5 mm (small-vessel group) in 41 patients (41 lesions) and >= 2.5 mm (large-vessel group) in 60 patients (61 lesions). Outcomes were compared according to pre-RVD. Results At 2-year angiographic follow-up no differences in late lumen loss (0.29 +/- 0.16 mm vs 0.25 +/- 0.22 mm, p=0.4391), and in-segment binary restenosis (5.3% vs 5.3% p=1.0000) were demonstrated between groups. In the small-vessel group, intravascular ultrasound analysis showed a significant increase in vessel area (12.25 +/- 3.47 mm(2) vs 13.09 +/- 3.38 mm(2) p=0.0015), scaffold area (5.76 +/- 0.96 mm(2) vs 6.41 +/- 1.30 mm(2) p=0.0008) and lumen area (5.71 +/- 0.98 mm(2) vs 6.20 +/- 1.27 mm(2) p=0.0155) between 6-months and 2-year follow-up. No differences in plaque composition were reported between groups at either time point. At 2-year clinical follow-up, no differences in ischaemia-driven major adverse cardiac events (7.3% vs 10.2%, p=0.7335), myocardial infarction (4.9% vs 1.7%, p=0.5662) or ischaemia-driven target lesion revascularisation (2.4% vs 8.5%, p=0.3962) were reported between small and large vessels. No deaths or scaffold thrombosis were observed. Conclusions Similar clinical and angiographic outcomes at 2-year follow-up were reported in small and large vessel groups. A significant late lumen enlargement and positive vessel remodelling were observed in small vessels.
引用
收藏
页码:98 / 105
页数:8
相关论文
共 29 条
[1]   Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials [J].
Agostoni, P ;
Biondi-Zoccai, GGL ;
Gasparini, GL ;
Anselmi, M ;
Morando, G ;
Turri, M ;
Abbate, A ;
McFadden, EP ;
Vassanelli, C ;
Zardini, P ;
Colombo, A ;
Serruys, PW .
EUROPEAN HEART JOURNAL, 2005, 26 (09) :881-889
[2]   RESTENOSIS AFTER CORONARY ANGIOPLASTY - THE PARADOX OF INCREASED LUMEN DIAMETER AND RESTENOSIS [J].
BEATT, KJ ;
SERRUYS, PW ;
LUIJTEN, HE ;
RENSING, BJ ;
SURYAPRANATA, H ;
DEFEYTER, P ;
VANDENBRAND, M ;
LAARMAN, GJ ;
ROELANDT, J ;
VANES, GA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (02) :258-266
[3]   Percutaneous coronary intervention for small vessel coronary artery disease [J].
Biondi-Zoccai, Giuseppe ;
Moretti, Claudio ;
Abbate, Antonio ;
Sheiban, Imad .
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2010, 11 (03) :189-198
[4]   Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? [J].
Brugaletta, Salvatore ;
Heo, Jung Ho ;
Garcia-Garcia, Hector M. ;
Farooq, Vasim ;
van Geuns, Robert Jan ;
de Bruyne, Bernard ;
Dudek, Dariusz ;
Smits, Pieter C. ;
Koolen, Jacques ;
McClean, Dougal ;
Dorange, Cecile ;
Veldhof, Susan ;
Rapoza, Richard ;
Onuma, Yoshinobu ;
Bruining, Nico ;
Ormiston, John A. ;
Serruys, Patrick W. .
EUROPEAN HEART JOURNAL, 2012, 33 (11) :1325-1333
[5]   Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study [J].
Brugaletta, Salvatore ;
Garcia-Garcia, Hector M. ;
Diletti, Roberto ;
Gomez-Lara, Josep ;
Garg, Scot ;
Onuma, Yoshinobu ;
Shin, Eun-Seok ;
van Geuns, Robert Jan ;
de Bruyne, Bernard ;
Dudek, Dariusz ;
Thuesen, Leif ;
Chevalier, Bernard ;
McClean, Dougal ;
Windecker, Stephan ;
Whitbourn, Robert ;
Dorange, Cecile ;
Veldhof, Susan ;
Rapoza, Richard ;
Sudhir, Krishnankutty ;
Bruining, Nico ;
Ormiston, John A. ;
Serruys, Patrick W. .
EUROINTERVENTION, 2011, 6 (09) :1110-1116
[6]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[7]   6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm [J].
Diletti, Roberto ;
Onuma, Yoshinobu ;
Farooq, Vasim ;
Gomez-Lara, Josep ;
Brugaletta, Salvatore ;
van Geuns, Robert Jan ;
Regar, Evelyn ;
de Bruyne, Bernard ;
Dudek, Dariusz ;
Thuesen, Leif ;
Chevalier, Bernard ;
McClean, Dougal ;
Windecker, Stephan ;
Whitbourn, Robert ;
Smits, Pieter ;
Koolen, Jacques ;
Meredith, Ian ;
Li, Dong ;
Veldhof, Susan ;
Rapoza, Richard ;
Garcia-Garcia, Hector M. ;
Ormiston, John A. ;
Serruys, Patrick W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (03) :258-264
[8]   Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial [J].
Dudek, Dariusz ;
Onuma, Yoshinobu ;
Ormiston, John A. ;
Thuesen, Leif ;
Miquel-Hebert, Karine ;
Serruys, Patrick W. .
EUROINTERVENTION, 2012, 7 (09) :1060-1061
[9]   Vessel size and long-term outcome after coronary stent placement [J].
Elezi, S ;
Kastrati, A ;
Neumann, FJ ;
Hadamitzky, M ;
Dirschinger, J ;
Schömig, A .
CIRCULATION, 1998, 98 (18) :1875-1880
[10]   Restenosis Delineating the Numerous Causes of Drug-Eluting Stent Restenosis [J].
Farooq, Vasim ;
Gogas, Bill D. ;
Serruys, Patrick W. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (02) :195-205